But in contrast, increasing studies indicate that PLA2G16 has oncogenic activity in tumors, including non-small cell lung cancer, osteosarcoma, colorectal cancer, gastric cancer, and rectum cancer [21, 27–30]. This evidence concerns the gene PLAAT3 and osteosarcoma.